BioWednesday Webinar: Technologies to Deliver the Promise of Cell and Gene Therapies

Registration is now closed. Please email alicia@onenucleus.com to be added to the waitlist. 

Cell and gene therapies offer new opportunities for treatments in areas of high un-met medical need.  But such cutting edge therapeutics need cutting edge technology.  Our BioWednesday Webinar will focus on the exciting scientific technologies and tools which are needed to develop cell and gene therapies, and ultimately improve patient outcomes.  Presentations will be followed by a wider Q&A session where there will be a chance to ask further questions around the specific value chain activities covered.  

Programme:
14.00 - Welcome

14.05 - Karin Schmitt, Chief Business Officer, Mogrify
Systematically transforming the development of ex vivo cell therapies and pioneering in vivo reprogramming therapies for diseases with high unmet clinical need

14.20 - Dr Ann S Macdonald, Business Development Manager-Cell and Gene Therapy, Thermo Fisher Scientific
Introducing the CTS Rotea Counter Flow Centrifugation System for Cell Therapy Manufacturing

14.35 - Dr Suzanne Riches, Field Application Scientist, Nexcelom Bioscience
High throughput cell analysis for cell therapy development - do more for less

14.50 - Moiz Ebrahimjee, Business Development Manager-Cell and Gene Therapy, Synthace Ltd
Intelligent Automation: Technologies to deliver the promise of cell and gene therapies

15.05 - Q&A

15.15 - Close

Prices
One Nucleus Members: Free
Non-Members: £50 +VAT
Academics: please contact Alicia